{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:12:18Z","timestamp":1739855538586,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,17]]},"DOI":"10.7759\/cureus.79161","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T14:13:02Z","timestamp":1739801582000},"source":"Crossref","is-referenced-by-count":0,"title":["Unmasking Latent Primary Hyperparathyroidism in Guillain-Barr\u00e9 Syndrome: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Masahiro","family":"Biyajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Oide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tsuyuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh MW","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, et al.. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013, 98:1122-9. 10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70083-4","article-title":"Subclinical and asymptomatic parathyroid disease: implications of emerging data","volume":"1","author":"Macfarlane DP","year":"2013","unstructured":"Macfarlane DP, Yu N, Leese GP. Subclinical and asymptomatic parathyroid disease: implications of emerging data. Lancet Diabetes Endocrinol. 2013, 1:329-40. 10.1016\/S2213-8587(13)70083-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-1-9-711","article-title":"Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism","volume":"1","author":"Albright F","year":"1941","unstructured":"Albright F, Burnett CH, Cope O, Parson W. Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J Clin Endocrinol. 1941, 1:711-6. 10.1210\/jcem-1-9-711","journal-title":"J Clin Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s007740050090","article-title":"The response of bone to unloading","volume":"17","author":"Bikle DD","year":"1999","unstructured":"Bikle DD, Halloran BP. The response of bone to unloading. J Bone Miner Metab. 1999, 17:233-44. 10.1007\/s007740050090","journal-title":"J Bone Miner Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0086","article-title":"Immobilization-induced hypercalcemia in a patient with renal failure","volume":"2021","author":"Gandhi A","year":"2021","unstructured":"Gandhi A, Mortensen M, Sunny S, Techathaveewat P, Targovnik J, Alsayed M. Immobilization-induced hypercalcemia in a patient with renal failure. Endocrinol Diabetes Metab Case Rep. 2021, 2021:10.1530\/EDM-21-0086","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1381\/096089202320995736","article-title":"Immobilization hypercalcemia in critical illness following bariatric surgery","volume":"12","author":"Alborzi F","year":"2002","unstructured":"Alborzi F, Leibowitz AB. Immobilization hypercalcemia in critical illness following bariatric surgery. Obes Surg. 2002, 12:871-3. 10.1381\/096089202320995736","journal-title":"Obes Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02985119","article-title":"The relationship between bone mineral density and immobilization duration in hemiplegic limbs","volume":"19","author":"Demirbag D","year":"2005","unstructured":"Demirbag D, Ozdemir F, Kokino S, Berkarda S. The relationship between bone mineral density and immobilization duration in hemiplegic limbs. Ann Nucl Med. 2005, 19:695-700. 10.1007\/BF02985119","journal-title":"Ann Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.11138\/ccmbm\/2016.13.1.046","article-title":"Immobilization induced hypercalcemia","volume":"13","author":"Cano-Torres EA","year":"2016","unstructured":"Cano-Torres EA, Gonz\u00e1lez-Cant\u00fa A, Hinojosa-Garza G, Castilleja-Leal F. Immobilization induced hypercalcemia. Clin Cases Miner Bone Metab. 2016, 13:46-7. 10.11138\/ccmbm\/2016.13.1.046","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref9","article-title":"Immobilization hypercalcemia following spinal cord injury","volume":"67","author":"Maynard FM","year":"1986","unstructured":"Maynard FM. Immobilization hypercalcemia following spinal cord injury. Arch Phys Med Rehabil. 1986, 67:41-4.","journal-title":"Arch Phys Med Rehabil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4158\/EP.8.3.213","article-title":"Immobilization-related hypercalcemia after renal failure in burn injury","volume":"8","author":"Peralta MC","year":"2002","unstructured":"Peralta MC, Gordon DL. Immobilization-related hypercalcemia after renal failure in burn injury. Endocr Pract. 2002, 8:213-6. 10.4158\/EP.8.3.213","journal-title":"Endocr Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24081","article-title":"Immobilization-induced hypercalcemia in COVID-19 with a prolonged intensive care unit stay","volume":"14","author":"Kannan L","year":"2022","unstructured":"Kannan L, Raj R, Rhoad W, Akella R, Jacob A. Immobilization-induced hypercalcemia in COVID-19 with a prolonged intensive care unit stay. Cureus. 2022, 14:e24081. 10.7759\/cureus.24081","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1986.00360200133022","article-title":"Immobilization hypercalcemia associated with Landry-Guillain-Barr\u00e9 syndrome. Successful therapy with combined calcitonin and etidronate","volume":"146","author":"Meythaler JM","year":"1986","unstructured":"Meythaler JM, Korkor AB, Nanda T, Kumar NA, Fallon M. Immobilization hypercalcemia associated with Landry-Guillain-Barr\u00e9 syndrome. Successful therapy with combined calcitonin and etidronate. Arch Intern Med. 1986, 146:1567-71.","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1097\/00003086-198703000-00038","article-title":"Immobilization-induced hypercalcemia and regional osteoporosis","author":"Clouston WM","year":"1987","unstructured":"Clouston WM, Lloyd HM. Immobilization-induced hypercalcemia and regional osteoporosis. Clin Orthop Relat Res. 1987, 247-52.","journal-title":"Clin Orthop Relat Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.06.005","article-title":"Parathyroid hormone independent hypercalcemia in adults","volume":"32","author":"Bollerslev J","year":"2018","unstructured":"Bollerslev J, Pretorius M, Heck A. Parathyroid hormone independent hypercalcemia in adults. Best Pract Res Clin Endocrinol Metab. 2018, 32:621-38. 10.1016\/j.beem.2018.06.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650061413","article-title":"Differential diagnosis of hypercalcemia","volume":"6 Suppl 2","author":"Lafferty FW","year":"1991","unstructured":"Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res. 1991, 6 Suppl 2:S51-9; discussion S61. 10.1002\/jbmr.5650061413","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan AA","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, et al.. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017, 28:1-19. 10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.1747","article-title":"Diagnosis and management of primary hyperparathyroidism across the Veterans Affairs health care system","volume":"179","author":"Alore EA","year":"2019","unstructured":"Alore EA, Suliburk JW, Ramsey DJ, et al.. Diagnosis and management of primary hyperparathyroidism across the Veterans Affairs health care system. JAMA Intern Med. 2019, 179:1220-7. 10.1001\/jamainternmed.2019.1747","journal-title":"JAMA Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2499","article-title":"Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study","volume":"98","author":"Rejnmark L","year":"2013","unstructured":"Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. J Clin Endocrinol Metab. 2013, 98:87-96. 10.1210\/jc.2012-2499","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.40.35","article-title":"Primary hyperparathyroidism masquerading as immobilization hypercalcemia: report of an illustrative case","volume":"40","author":"Monno S","year":"1993","unstructured":"Monno S, Yokozawa T, Mizushima Y, et al.. Primary hyperparathyroidism masquerading as immobilization hypercalcemia: report of an illustrative case. Endocr J. 1993, 40:35-9. 10.1507\/endocrj.40.35","journal-title":"Endocr J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X241241439","article-title":"A case report of primary hyperparathyroidism in an adolescent during Ramadan fast","volume":"12","author":"Eze UJ","year":"2024","unstructured":"Eze UJ, Elfadil S. A case report of primary hyperparathyroidism in an adolescent during Ramadan fast. SAGE Open Med Case Rep. 2024, 12:2050313X241241439. 10.1177\/2050313X241241439","journal-title":"SAGE Open Med Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5414\/CN111231","article-title":"Treatment of hypokalemia with amiloride unmasked hypercalcemia and hyperparathyroidism: A case report","volume":"100","author":"Golbus AE","year":"2023","unstructured":"Golbus AE, Freidin N. Treatment of hypokalemia with amiloride unmasked hypercalcemia and hyperparathyroidism: A case report. Clin Nephrol. 2023, 100:290-2. 10.5414\/CN111231","journal-title":"Clin Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2020-0113","article-title":"Hypercalcemic patient diagnosed with primary hyperparathyroidism after dapagliflozin treatment","volume":"6","author":"Akhanl\u0131 P","year":"2020","unstructured":"Akhanl\u0131 P, Hepsen S, Ucan B, Saylam G, Cakal E. Hypercalcemic patient diagnosed with primary hyperparathyroidism after dapagliflozin treatment. AACE Clin Case Rep. 2020, 6:e319-21. 10.4158\/ACCR-2020-0113","journal-title":"AACE Clin Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-015-0587-1","article-title":"All-trans-retinoic-acid unmasking hypercalcemia of hyperparathyroidism","volume":"32","author":"Yanamandra U","year":"2016","unstructured":"Yanamandra U, Sahu KK, Khadwal A, Prakash G, Varma SC, Malhotra P. All-trans-retinoic-acid unmasking hypercalcemia of hyperparathyroidism. Indian J Hematol Blood Transfus. 2016, 32:41-5. 10.1007\/s12288-015-0587-1","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.157427","article-title":"Unmasking of primary hyperparathyroidism by Vitamin D therapy","volume":"25","author":"Bala S","year":"2015","unstructured":"Bala S, Shah B, Rajput P, Rao P. Unmasking of primary hyperparathyroidism by Vitamin D therapy. Indian J Nephrol. 2015, 25:377-9. 10.4103\/0971-4065.157427","journal-title":"Indian J Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-12-14","article-title":"A case report: Giant cystic parathyroid adenoma presenting with parathyroid crisis after Vitamin D replacement","volume":"12","author":"Asghar A","year":"2012","unstructured":"Asghar A, Ikram M, Islam N. A case report: Giant cystic parathyroid adenoma presenting with parathyroid crisis after Vitamin D replacement. BMC Endocr Disord. 2012, 12:14. 10.1186\/1472-6823-12-14","journal-title":"BMC Endocr Disord"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1258\/0004563041731619","article-title":"Vitamin D deficiency masking primary hyperparathyroidism","volume":"41","author":"Hannan FM","year":"2004","unstructured":"Hannan FM, Fairney A, Johnston DG. Vitamin D deficiency masking primary hyperparathyroidism. Ann Clin Biochem. 2004, 41:405-7. 10.1258\/0004563041731619","journal-title":"Ann Clin Biochem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.866.813","article-title":"Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism","volume":"73","author":"Taylor AV","year":"1997","unstructured":"Taylor AV, Wise PH. Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism. Postgrad Med J. 1997, 73:813-5. 10.1136\/pgmj.73.866.813","journal-title":"Postgrad Med J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/003693309504000607","article-title":"Cyclical etidronate and calcium carbonate (with citrate) supplementation for osteoporosis unmasking primary hyperparathyroidism","volume":"40","author":"Forbes RB","year":"1995","unstructured":"Forbes RB, Grant DJ, MacWalter RS. Cyclical etidronate and calcium carbonate (with citrate) supplementation for osteoporosis unmasking primary hyperparathyroidism. Scott Med J. 1995, 40:177-8. 10.1177\/003693309504000607","journal-title":"Scott Med J"},{"key":"ref29","article-title":"Myxedema masking primary hyperparathyroidism","volume":"85","author":"Peter SA","year":"1993","unstructured":"Peter SA, Brignol YF. Myxedema masking primary hyperparathyroidism. J Natl Med Assoc. 1993, 85:471-2.","journal-title":"J Natl Med Assoc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.59.688.118","article-title":"Primary hyperparathyroidism unmasked by donor nephrectomy","volume":"59","author":"Hollands MJ","year":"1983","unstructured":"Hollands MJ, Williams G. Primary hyperparathyroidism unmasked by donor nephrectomy. Postgrad Med J. 1983, 59:118-9. 10.1136\/pgmj.59.688.118","journal-title":"Postgrad Med J"},{"key":"ref31","article-title":"Hyperparathyroidism in association with lithium therapy","volume":"42","author":"Graze KK","year":"1981","unstructured":"Graze KK. Hyperparathyroidism in association with lithium therapy. J Clin Psychiatry. 1981, 42:38-9.","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992","volume":"126","author":"Wermers RA","year":"1997","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ 3rd. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997, 126:433-40. 10.7326\/0003-4819-126-6-199703150-00003","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler ML","year":"2015","unstructured":"Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015, 73:1-7. 10.1016\/j.bone.2014.12.003","journal-title":"Bone"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4821","article-title":"Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality","volume":"38","author":"Sing CW","year":"2023","unstructured":"Sing CW, Lin TC, Bartholomew S, et al.. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. J Bone Miner Res. 2023, 38:1064-75. 10.1002\/jbmr.4821","journal-title":"J Bone Miner Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340647-unmasking-latent-primary-hyperparathyroidism-in-guillain-barr-syndrome-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T14:13:05Z","timestamp":1739801585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340647-unmasking-latent-primary-hyperparathyroidism-in-guillain-barr-syndrome-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.79161","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}